Reflections on the 2023 G7’s Global Health Commitments
This webinar is a kick-off for the Hiroshima G7 Global Health Follow-up Initiative, and aims to reflect on the 2023 G7 communique and past G7 commitments.
JCIE Publication | Strengthening the Clinical Trial Site Network in Asia to Accelerate Harmonization of Development Systems and Regulations
This report, available in both English and Japanese, outlines the Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia’s strategy recommendations for developing and expanding the network of Asian hubs as a way to accelerate harmonization of development systems.
Hiroshima G7 Task Force: Recommendations for Promoting Global Solidarity Towards a More Resilient Health System
JCIE co-hosted a special webinar with Pandemic Action Network (PAN), and the University of Tokyo’s Institute for Future Initiatives to discuss JCIE’s Hiroshima G7 Global Health Task Force recommendations for Japan’s G7 global health agenda.
Roundtable Discussion with Hiroshima G7 Global Health Taskforce Director in Washington DC
In 2023, Japan will host the G7 Summit in Hiroshima. JCIE has established a Hiroshima G7 Global Health Task Force to make recommendations to the Japanese government on the G7 agenda for global health. This roundtable was an opportunity for leading US policymakers and experts to hear from and offer feedback to the director of the Task Force, Dr. Hideaki Shiroyama.
Hiroshima G7 Global Health Task Force Recommendations for the G7 Meetings in Japan
This report, available in both English and Japanese, outlines the Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia’s strategy recommendations for a COVID-19 emergency response.
Hiroshima G7 Global Health Task Force Dialogue Series
In 2023, Japan will host the G7 Summit in Hiroshima. JCIE has established a Hiroshima G7 Global Health Task Force to make recommendations to the Japanese government on the G7 agenda for global health. This roundtable was an opportunity for leading US policymakers and experts to hear from and offer feedback to the director of the Task Force, Dr. Hideaki Shiroyama.
Launch of the G7 Global Health Task Force
Ahead of the G7 Summit, JCIE has established the 2023 G7 Global Health Task Force under the Executive Committee on Global Health and Human Security to make recommendations to the Japanese government on the G7 agenda and concrete measures to be promoted for global health in the context of the rapidly changing global health architecture.
The Roles of Germany and Japan in Global Health IV
Japanese and German politicians, policy experts, business leaders, and global health experts participated in a hybrid forum to utilize the countries’ bilateral relationship to discuss key issues in global health and how to pass the G7 presidency baton from Germany to Japan in 2023.
JCIE’s G7 Global Health Task Force Publishes Comments in the Lancet
The Lancet published a comment from the Hiroshima G7 Global Health Task Force, outlining the Task Force’s recommendations for tackling some of the main challenges in global health: advancing the resilience of health systems to address public health emergencies and enhancing global solidarity by transforming the global health architecture within the context of current geopolitical tensions.
Briefing on the ACT-Accelerator at the Special Session of the Executive Committee on Global Health and Human Security
On May 19th, ten leaders of the global health organizations that comprise the Access to COVID-19 Tools (ACT) Accelerator, as well as Ambassador Carl Bildt, WHO Special Envoy for ACT-Accelerator, joined the Special Session of the Executive Committee to explain how this unprecedented global health partnership is helping develop and equitably distribute critical COVID-19 tools.
